Analysis of Peripheral Blood Mononuclear Cell Phenotypes during Treatment with Fingolimod: A 2-Year Study of a German Cohort of Patients with Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Dehmel, Thomas [2 ]
Ingenhoven, Kathleen [2 ]
Frenken, Pia [2 ]
Hermsen, Derik [3 ]
Hartung, Hans [1 ]
Kieseier, Bernd [2 ]
Wamke, Clemens [4 ]
机构：
[1] Heinrich Heine Univ Duesseldorf, Dusseldorf, Germany
[2] Heinrich Heine Univ, Dusseldorf, Germany
[3] Heinrich Heine Univ, Cent Inst Clin Chem & Lab Med, Dusseldorf, Germany
[4] Univ Duesseldorf, Klin Fuer Neurol, Dusseldorf, Germany
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.097
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal study
    Dennis A.M. van Gorp
    Karin van der Hiele
    Marco A.P. Heerings
    Peter J. Jongen
    Jac J.L. van der Klink
    Michiel F. Reneman
    Edo P.J. Arnoldus
    Ernesto A.C. Beenakker
    Jeroen J.J. van Eijk
    Stephan T.F.M. Frequin
    Koen de Gans
    Elske Hoitsma
    Jop P. Mostert
    Wim I.M. Verhagen
    Désirée Zemel
    Leo H. Visser
    Huub A.M. Middelkoop
    Neurological Sciences, 2019, 40 : 2555 - 2564
  • [42] Voxel-based analysis of microstructural tissue damage in relapsing-remitting multiple sclerosis patients: a 2-year MRI longitudinal study
    Hannoun, S.
    Durand-Dubief, F.
    Ibarrola, D.
    Comte, J-C.
    Confavreux, C.
    Cotton, F.
    Sappey-Marinier, D.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S169 - S169
  • [43] Transcriptional effects of fingolimod treatment on peripheral T cells in relapsing remitting multiple sclerosis patients
    Sferruzza, Giacomo
    Clarelli, Ferdinando
    Mascia, Elisabetta
    Ferre, Laura
    Ottoboni, Linda
    Sorosina, Melissa
    Santoro, Silvia
    Filippi, Massimo
    Provero, Paolo
    Esposito, Federica
    PHARMACOGENOMICS, 2021, 23 (03) : 161 - 171
  • [44] Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients
    Studer, Valeria
    Ferri, Anna
    Perugini, Jacopo
    Clerici, Valentina Torri
    Confalonieri, Paolo
    Antozzi, Carlo
    Mantegazza, Renato
    Schilke, Edoardo
    Brambilla, Laura
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 25 - 26
  • [45] COST-EFFECTIVENESS OF DACLIZUMAB VERSUS FINGOLIMOD IN THE TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN NORWAY
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Haines, P.
    Liu, Y.
    Bjornstad, B. M.
    Haukaas, F. S.
    VALUE IN HEALTH, 2016, 19 (07) : A433 - A433
  • [46] Prognostic parameters of medium-term response to fingolimod treatment in relapsing-remitting multiple sclerosis patients
    Ferre, L.
    Clarelli, F.
    Mogavero, A.
    Romeo, M.
    Sangalli, F.
    Moiola, L.
    Martinelli, V.
    Leocani, L.
    Filippi, M.
    Esposito, F.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 489 - 489
  • [47] Radiological Evidence for the Long-Term Effect of Fingolimod Treatment in Patients with Relapsing-Remitting Multiple Sclerosis
    Cohen, Jeffrey
    Tenenbaum, Nadia
    Bhatt, Alit
    Pimentel, Ron
    Kappos, Ludwig
    NEUROLOGY, 2017, 89 (08) : E103 - E103
  • [48] Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis
    Crespo, C.
    Izquierdo, G.
    Garcia-Ruiz, A.
    Granell, M.
    Brosa, M.
    NEUROLOGIA, 2014, 29 (04): : 210 - 217
  • [49] Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Hanni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Ozgur
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (06) : 777 - 785
  • [50] Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
    Silfverberg, Thomas
    Zjukovskaja, Christina
    Ljungman, Per
    Nahimi, Adjmal
    Ahlstrand, Erik
    Dreimane, Arta
    Einarsdottir, Sigrun
    Fagius, Jan
    Iacobaeus, Ellen
    Hagglund, Hans
    Lange, Niclas
    Lenhoff, Stig
    Lycke, Jan
    Mellergard, Johan
    Piehl, Fredrik
    Svenningsson, Anders
    Tolf, Andreas
    Cherif, Honar
    Carlson, Kristina
    Burman, Joachim
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (02): : 125 - 133
12345